Warning: fopen(/home/virtual/colon/journal/upload/ip_log/ip_log_2024-10.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 95 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 96 Waiting and Hope: Optimal Time Interval for Surgery After Long-Course Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
Skip Navigation
Skip to contents

Ann Coloproctol : Annals of Coloproctology

OPEN ACCESS
SEARCH
Search
Advanced Search
mobile menu button

Articles

Page Path
HOME > Ann Coloproctol > Volume 34(5); 2018 > Article
Editorial
 Waiting and Hope: Optimal Time Interval for Surgery After Long-Course Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
Chang Hyun Kimorcid
Annals of Coloproctology 2018;34(5):227-228.
DOI: https://doi.org/10.3393/ac.2018.08.16
Published online: October 31, 2018

Department of Surgery, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, Korea

Correspondence to: Chang Hyun Kim, M.D. Department of Surgery, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, 322 Seoyang-ro, Hwasun 58128, Korea Tel: +82-61-379-7646, Fax: +82-61-379-7661 E-mail: cksantiago8@gmail.com

Copyright © 2018 The Korean Society of Coloproctology

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

next
  • 3,423 Views
  • 103 Download
Full Article

Download PDF Download PDF

See the article "Optimal Time Interval for Surgery After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer: Analysis of Health Insurance Review and Assessment Service Data" on page 241.
See Article on Page [Related article:] 241-247
Colorectal cancer is the most often diagnosed malignancy worldwide and is the second most common cancer in South Korea [1]. The treatment of locally advanced rectal cancer has changed continuously. Recently, preoperative chemoradiotherapy (CRT) has been the mainstay of treatment for this disease as it confers a high rate of local control and sphincter preservation [2]. Parameters for tumor sterilization related with radiotherapy are the total radiation dose, the dose per each fraction, and the time interval from the completion of radiotherapy to pathologic assessment of the tumor [3]. Many plausible methods, such as radiation dosage, type of concurrent chemotherapy, and various modalities of radiotherapy, have been tested. Meanwhile, the time interval from the day of completion of CRT to surgery has been recognized as a modifiable factor that may alter oncologic outcome [4]. Pathologic complete response (pCR) is now regarded as an independent predictor of long-term outcomes following preoperative CRT in patients with locally advanced rectal cancer. In terms of radiobiology, the radiation is given in small doses (1.8–2.0 Gy) for 5 to 7 weeks. The reason for this fractionated schedule is to permit the recovery of normal tissues from sublethal radiation damage. However, repopulation of tumor cells also occurs [5]. In a rectal adenocarcinoma, significant repopulation of tumor cells occurs 4 weeks after the completion of long-course radiotherapy [6], but this phenomenon can be delayed by combining chemotherapeutic agents [7].
Although a consensus about when to perform surgery after preoperative CRT is still lacking, a minimum of 6 to 8 weeks after completion of preoperative CRT is recommended to achieve maximal tumor shrinkage. Several retrospective studies reported that increasing the delay after preoperative CRT is associated with greater tumor regression. However, the actual impact of delaying surgery is unknown. All of these studies have unavoidable biases. For example, the selection of surgical timing was determined by the surgeons and was influenced by the tumor response to preoperative CRT. The Lyon trial (short-course CRT) [4] and the GRECCAR-6 trial (long-course CRT) [8] were the only 2 prospective randomized studies on this issue. Especially, in the GRECCAR-6 trial, waiting 11 weeks after completion of preoperative CRT did not show any higher achievement of pCR after surgery, and the speculation is that new tumor sterilization after 6 to 8 weeks cannot be anticipated; instead, tumor re-growth by repopulation will be accelerated [8].
In this regard, Kim et al. [9] reported the effect of this time interval on the pathologic response for patients with rectal cancer. For the first time on this issue, they analyzed data selected from data provided by Health Insurance Review and Assessment (HIRA) Service. Unfortunately, the study had various limitations in terms of both the small number of patients, despite the data being drawn from a national database, and the short follow-up time. As recognized by Kim et al. [9], their study did not extract all the patient data—100 patients from each institution and the dates of radiotherapy and surgery were not available in the HIRA database in the middle of the study period; therefore, a clear conclusion could not be reached. Nevertheless, the author showed that delaying surgery until 9 to 11 weeks after long-course preoperative CRT increases tumor downstaging while delaying it by more than 11 weeks does not provide additional tumor regression. These results are consistent with those of the GRECCAR-6 trial and the above-mentioned radiobiology [8].
In the future of healthcare, the use of big data will be inevitable, and the healthcare sector will be one of the sectors expected to benefit the most from big data. In Korea, the HIRA database has been widely used in many clinical studies. Along with this, the Korean Society of Coloproctology has recently been working on building a national database for colorectal cancer. In the future, we hope to see the results of representative research that uses these databases to overcome the above-mentioned limitations.

CONFLICT OF INTEREST

No conflicts of interest are reported.

  • 1. Jung KW, Won YJ, Kong HJ, Lee ES; Community of Population-Based Regional Cancer Registries. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat 2018;50:303–16.ArticlePubMedPMCPDF
  • 2. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731–40.ArticlePubMed
  • 3. Berger C, de Muret A, Garaud P, Chapet S, Bourlier P, Reynaud-Bougnoux A, et al. Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications. Int J Radiat Oncol Biol Phys 1997;37:619–27.ArticlePubMed
  • 4. Francois Y, Nemoz CJ, Baulieux J, Vignal J, Grandjean JP, Partensky C, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999;17:2396. ArticlePubMed
  • 5. Kim JJ, Tannock IF. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer 2005;5:516–25.ArticlePubMedPDF
  • 6. Gasinska A, Richter P, Darasz Z, Niemiec J, Bucki K, Malecki K, et al. Gender-related differences in repopulation and early tumor response to preoperative radiotherapy in rectal cancer patients. J Gastrointest Surg 2011;15:1568–76.ArticlePubMed
  • 7. Peters LJ, Withers HR. Applying radiobiological principles to combined modality treatment of head and neck cancer--the time factor. Int J Radiat Oncol Biol Phys 1997;39:831–6.ArticlePubMed
  • 8. Lefevre JH, Mineur L, Kotti S, Rullier E, Rouanet P, de Chaisemartin C, et al. Effect of interval (7 or 11 weeks) between neoadjuvant radiochemotherapy and surgery on complete pathologic response in rectal cancer: a multicenter, randomized, controlled trial (GRECCAR-6). J Clin Oncol 2016;34:3773–80.ArticlePubMed
  • 9. Kim MJ, Cho JS, Kim EM, Ko WA, Oh JH. Optimal time interval for surgery after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: analysis of Health Insurance Review and Assessment Service data. Ann Coloproctol 2018;34:241–7.ArticlePubMedPMCPDF

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      • PubReader PubReader
      • ePub LinkePub Link
      • Cite this Article
        Cite this Article
        export Copy Download
        Close
        Download Citation
        Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
        Format:
        • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
        • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
        Include:
        • Citation for the content below
        Waiting and Hope: Optimal Time Interval for Surgery After Long-Course Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
        Ann Coloproctol. 2018;34(5):227-228.   Published online October 31, 2018
        DOI: https://doi.org/10.3393/ac.2018.08.16
        Close
      • XML DownloadXML Download
      Related articles
      Waiting and Hope: Optimal Time Interval for Surgery After Long-Course Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
      Waiting and Hope: Optimal Time Interval for Surgery After Long-Course Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
      Ann Coloproctol : Annals of Coloproctology Twitter Facebook
      © Korean Society of Coloproctology.
      TOP